Concepedia

Christopher M. Jay

CM

5

Publications

116

Citations

5

H-Index

2004

Active since

Affiliations

Gradalis (United States)(Current)

Texas Oncology

Mary Crowley Cancer Research Center

Medical City Dallas Hospital

Christopher M. Jay is an author at Gradalis (United States) specializing in medicine, pathogenesis, and clinical microbiology.

Top concepts

Publications per year

2004–2018

5

Publications

5

Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma

Donald D. Rao, Christopher M. Jay, Zhaohui Wang et al. · Molecular Therapy · 2016 · 42 citations · Full text

Enterotoxigenic K99+ Escherichia coli attachment to host cell receptors inhibited by recombinant pili protein

Christopher M. Jay, Shoba Bhaskaran, Keerti S. Rathore et al. · Veterinary Microbiology · 2004 · 31 citations

, , +8

Phase 1 Trial of Bi-shRNA STMN1 BIV in Refractory Cancer

Minal Barve, Zhaohui Wang, Padmasini Kumar et al. · Molecular Therapy · 2015 · 20 citations · Full text

KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex

Donald D. Rao, Xiuquan Luo, Zhaohui Wang et al. · PLoS ONE · 2018 · 13 citations · Full text

, , +19

Preclinical Biodistribution and Safety Evaluation of a pbi-shRNA STMN1 Lipoplex after Subcutaneous Delivery

Zhaohui Wang, Christopher M. Jay, Courtney Evans et al. · Toxicological Sciences · 2016 · 10 citations · Full text

Rows per page

1–5 of 5